Selected human leukocyte antigen class II polymorphisms and risk of adult glioma

Journal of Neuroimmunology

Volumn 233, Issue 1-2, 2011, Pages 185-191

  Bassig, Bryan A ^a   Inskip, Peter D ^b   Burdette, Laurie ^c   Shapiro, William R ^d   Selker, Robert G ^e   Fine, Howard A ^b   Loeffler, Jay S ^f   Black, Peter M ^g   Dubrow, Robert ^a   Brenner, Alina V ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d BARROW NEUROLOGICAL INSTITUTE   (United States)

^e WESTERN PENNSYLVANIA HOSPITAL   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Brain tumors; DQB1*DRB1; Glioma; HLA polymorphisms

Indexed keywords

HLA A2 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LOCUS; GENOTYPE; GLIOMA; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 79953297256     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.11.005     Document Type: Article

References (56)

1. Alaez C., Lin L., Flores H.A., Vazquez M., Munguia A., Mignot E., Haro R., Baker H., Gorodezky C. Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexican patients: a relationship between HLA and gender is suggested. BMC Med. Genet. 2008, 9:79.
2. Barnholtz-Sloan J.S., Sloan A.E., Schwartz A.G. Cancer of the Brain and Other Central Nervous System (Ch.25). SEER Survival Monograph: Cancer Survival Among Adults: U.S.SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD, 2007 2007, L.A.G. Ries, J.L. Young, G.E. Keel, M.P. Eisner, Y.D. Lin, M.-J. Horner (Eds.).
3. Bateman A.C., Turner S.J., Theaker J.M., Howell W.M. HLA-DQB*10303 and *0301 alleles infuence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian population. Tissue Antigens 1998, 52:67-73.
4. Bondinas G.P., Moustakas A.K., Papadopoulos G.K. The spectrum of HLA-DQ and HLA-DR alleles, 2006: a listing correlating sequence and structure with function. Immunogenetics 2007, 59:539-553.
5. Bondy M.L., Scheurer M.E., Malmer B., Barnholtz-Sloan J.S., Davis F.G., Il'yasova D., Kruchko C., McCarthy B.J., Rajaraman P., Schwartzbaum J.A., Sadetzki S., Schlehofer B., Tihan T., Wiemels J.L., Wrensch M., Buffler P.A. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008, 113:1953-1968.
6. Brenner A.V., Butler M.A., Wang S.S., Ruder A.M., Rothman N., Schulte P.A., Chanock S.J., Fine H.A., Linet M.S., Inskip P.D. Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis 2007, 28:2543-2547.
7. Brenner A.V., Linet M.S., Fine H.A., Shapiro W.R., Selker R.G., Black P.M., Inskip P.D. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int. J. Cancer 2002, 99:252-259.
8. Buc M., Bucova M., Javor J., Krivosikova M., Stuchlikova M., Shawkatova I., Michalkova D., Barak L., Jancova E., Petrek M. Associations between HLA class II alleles and type 1 diabetes mellitus in the Slovak population. Endocr. Regul. 2006, 40:1-6.
9. Castro F.A., Haimila K., Sareneva I., Schmitt M., Lorenzo J., Kunkel N., Kumar R., Forsti A., Kjellberg L., Hallmans G., Lehtinen M., Hemminki K., Pawlita M. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population - a candidate gene approach. Int. J. Cancer 2009, 125:1851-1858.
10. CBTRUS Statistical Report (2010): Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2006. Source: Central Brain Tumor Registry of the United States. http://www.cbtrus.org.
11. Chaudhuri S., Cariappa A., Tang M., Bell D., Haber D.A., Isselbacher K.J., Finkelstein D., Forcione D., Pillai S. Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. Proc. Natl Acad. Sci. USA 2000, 97:11451-11454.
12. Chuong B.D., Batzoglou S. What is the expectation maximization algorithm?. Nat. Biotechnol. 2008, 26:897-899.
13. Daly A.K., Steen V.M., Fairbrother K.S., Idle J.R. CYP2D6 multialleism. Meth. Enzymol. 1996, 272:199-210.
14. de Moerloose P., Jeannet M., Martin-Achard A., de Tribolet N., Seiler R., Guanella N. HLA and glioma. Tissue Antigens 1978, 12:146-148.
15. Erlich H., Valdes A.M., Noble J., Carlson J.A., Varney M., Concannon P., Mychaleckyj J.C., Todd J.A., Bonella P., Fear A.L., Lavant E., Louey A., Moonsamy P. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008, 57:1084-1092. Type 1 Diabetes Genetics Consortium.
16. Fallin D., Cohen A., Essioux L., Chumakov I., Blumenfeld M., Cohen D., Schork N.J. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's Disease. Genome Res. 2001, 11:143-151.
17. Ferreira J.A., Zwinderman A.H. On the Benjamini-Hochberg method. Ann Stat 2006, 34:1827-1849.
18. Giza S., Galli-Tsinopoulou A., Lazidou P., Trachana M., Goulis D. HLA-DQB1*05 association with Hashimoto's thyroiditis in children of Northern Greek origin. Indian Pediatr. 2008, 45:493-496.
19. Gorodezky C., Alaez C., Murguia A., Rodriguez A., Balladares S., Vazquez M., Flores H., Robles C. HLA and autoimmune diseases: type 1 diabetes (T1D) as an example. Autoimmun. Rev. 2006, 5:187-194.
20. Guerini F.R., Agliardi C., Zanzottera M., Delbue S., Pagani E., Tinelli C., Boldorini R., Car P.G., Veggiani C., Ferrante P. Human Leukocyte antigen distribution analysis in North Italian brain Glioma patients: an association with HLA-DRB1*14. J. Neurooncol. 2006, 77:213-217.
21. Guja C., Guja L., Nutland S., Rance H., Sebastien M., Todd J.A., Ionescu-Tirgoviste C. Type 1 diabetes genetic susceptibility encoded by HLA DQB*1 genes in Romania. J. Cell. Mol. Med. 2004, 8:249-256.
22. Hildesheim A., Schiffman M., Scott D.R., Marti D., Kissner T., Sherman M.E., Glass A.G., Manos M.M., Lorincz A.T., Kurman R.J., Buckland J., Rush B.B., Carrington M. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol. Biomark. Prev. 1998, 7:1035-1041.
23. Hor H., Kutalik Z., Dauvilliers Y., Valsesia A., Lammers G.J., Donjacour C.E., Iranzo A., Santamaria J., Peraita Adrados R., Vicario J.L., Overeem S., Arnulf I., Theodorou I., Jennum P., Knudsen S., Bassetti C., Mathis J., Lecenderux M., Mayer G., Geisler P., Beneto A., Petit B., Pfister C., Burki J.V., Didelot G., Billiard M., Ercilla G., Verduijn W., Claas F.H., Vollenwider P., Waeber G., Waterworth D.M., Mooser V., Heinzer R., Beckmann J.S., Bergmann S., Tafti M. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat. Genet. 2010, 42:786-789.
24. Il'yasova D., McCarthy B., Marcello J., Schildkraut J.M., Moorman P.G., Krishnamachari B., Ali-Osman F., Bigner D.D., Davis F. Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls. Cancer Epidemiol. Biomark. Prev. 2009, 18:1232-1238.
25. Inskip P.D., Hatch E.E., Stewart P.A., Heineman E.F., Ziegler R.G., Dosemeci M., Parry D., Rothman N., Boice J.D., Wilcosky T.C., Watson D.J., Shapiro W.R., Selker R.G., Fine H.A., Black P.M., Loeffler J.S., Linet M.S. Study Design for a case-control investigation of cellular telephones and other risk factors for brain tumors in adults. Radiat. Prot. Dosim. 1999, 86:45-52.
26. Invernizzi P., Selmi C., Poli F., Frison S., Floreani A., Alvaro D., Almasio P., Rosina F., Marzioni M., Fabris L., Muratori L., Qi L., Seldin M.F., Gershwin M.E., Podda M. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology 2008, 48:1906-1912. Italian PBC Genetic Study Group.
27. Juhn Y.J., Kita H., Lee L.A., Smith R.W., Bagniewski S.M., Weaver A.L., Pankratz V.S., Jacobson R.M., Poland G.A. Childhood asthma and human leukocyte antigen type. Tissue Antigens 2007, 69:38-46.
28. Karell K., Louka A.S., Moodie S.J., Ascher H., Clot F., Greco L., Ciclitira P.J., Sollid L.M., Partanen J. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum. Immunol. 2003, 64:469-477.
29. Kubler K., Arndt P.F., Wardelmann E., Krebs D., Kuhn W., van der Ven K. HLA-class II haplotype associations with ovarian cancer. Int. J. Cancer 2006, 119:2980-2985.
30. Laadhar L., Toumi A., Kallel-Sellami M., Zitouni M., Bouraoui S., Maherzi A., Makni S., Ben Hariz M. HLA class II polymorphism in children with coeliac disease in Tunisia: is there any influence on clinical manifestation?. Eur. J. Gastroenterol. Hepatol. 2009, 21:1286-1290.
31. Laaksonen M., Pastinen T., Sjoroos M., Kuokkanen S., Ruutiainen J., Sumelahti M.L., Reijonen H., Salonen R., Wikstrom J., Panelius M., Partanen J., Tienari P.J., Llonen J. HLA class II associated risk and protection against multiple sclerosis - a Finnish Family Study. J. Neuroimmunol. 2002, 122:140-145.
32. Lampe J.B., Gossrau G., Herting B., Kempe A., Sommer U., Fussel M., Weber M., Koch R., Reichmann H. HLA typing and Parkinson's disease. Eur. Neurol. 2003, 50:64-68.
33. La Torre D., Maugeri R., Angileri F.F., Pezzino G., Conti A., Cardali S.M., Calisto A., Sciarrone G., Misefari A., Germano A., Tomasello F. Human leukocyte antigen frequency in human high-grade gliomas: a case-control study in Sicily. Neurosurgery 2009, 64:1082-1088.
34. Little A.M. An overview of HLA typing for hematopoietic stem cell transplantation. Bone Marrow and Stem Cell Transplantation 2007, Vol. 134:35-49. Springer-Verlag, New York, NY. M. Beksac (Ed.).
35. Machulla H.K., Steinborn F., Schaaf A., Heidecke V., Rainov N.G. Brain glioma and human leukocyte antigens (HLA)- is there an association. J. Neurooncol. 2001, 52:253-261.
36. Martinetti M., Biagi F., Badulli C., Feurle G.E., Muller C., Moos V., Schneider T., Marth T., Marchese A., Trotta L., Sachetto S., Pasi A., De Silvestri A., Salvaneschi L., Corazza G.R. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's Disease. Gastroenterology 2009, 136:2289-2294.
37. McTernan C.L., Mijovic C.H., Cockram C.S., Barnett A.H. The nucleotide sequence of a new DMB allele, DMB*0106. Tissue Antigens 2000, 55:470-472.
38. Mignot E., Lin L., Rogers W., Honda Y., Qiu X., Lin X., Okun M., Hohjoh H., Miki T., Hsu S., Leffell M., Grumet F., Fernandez-Vina M., Honda M., Risch N. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am. J. Hum. Genet. 2001, 68:686-699.
39. Nitta T., Ebato M., Sato K. Association of malignant glioma with the human leukocyte antigen, HLA-A24(9). Neurosurg. Rev. 1994, 17:211-215.
40. Rajaraman P., Brenner A.V., Butler M.A., Wang S.S., Pfeiffer R.M., Ruder A.M., Linet M.S., Yeager M., Wang Z., Orr N., Fine H.A., Kwon D., Thomas G., Rothman N., Inskip P.D., Chanock S.J. Common variation in genes related to innate immunity and risk of adult glioma. Cancer Epidemiol. Biomark. Prev. 2009, 18:1651-1658.
41. Rekha P.L., Valluri V., Rakh S.S., Pantula V., Ishaq M. Association of HLA DQ B1* and HLA DR B1* alleles with goitrous juvenile autoimmune hypothyroidism - a case control study. J. Clin. Immunol. 2007, 27:486-490.
42. Sanjeevi C.B. HLA-DQ6-mediated protection in IDDM. Hum. Immunol. 2000, 61:148-153.
43. Scheurer M.E., Amirian E., Cao Y., Gilbert M.R., Aldape K.D., Kornguth D.G., El-Zein R., Bondy M.L. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma. Clin. Cancer Res. 2008, 14:6640-6646.
44. Schoemaker M.J., Swerdlow A.J., Hepworth S.J., McKinney P.A., van Tongeren M., Muir K.R. History of allergies and risk of glioma in adults. Int. J. Cancer 2006, 119:2165-2172.
45. Schubert M.S., Hutcheson P.S., Graff R.J., Santiago L., Slavin R.G. HLA-DQB1 *03 in allergic fungal sinusitis and other chronic hypertrophic rhinosinusitis disorders. J. Clin. Immunol. 2004, 114:1376-1383.
46. Schwartzbaum J., Ahlbom A., Malmer B., Lönn S., Brookes A.J., Doss H., Debinski W., Henriksson R., Feychting M. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res. 2005, 65:6459-6465.
47. Seidl C., Korbitzer J., Badenhoop K., Seifried E., Hoelzer D., Zanelli E., Kaltwasser J.P. Protection against severe disease is conferred by DERAA-bearing HLA-DRB1 alleles among HLA-DQ3 and HLA-DQ5 positive rheumatoid arthritis patients. Hum. Immunol. 2001, 62:523-529.
48. Sénéchal H., Geny S., Desvaux F.X., Busson M., Mayer C., Aron Y., Oster J.P., Bessot J.C., Peltre G., Pauli G., Swierczewski E. Genetics and specific immune response in allergy to birch pollen and food: evidence of a strong, positive association between atopy and the HLA class II allele HLA-DR7. J. Allergy Clin. Immunol. 1999, 104:395-401.
49. Sidney J., Steen A., Moore C., Ngo S., Chung J., Peters B., Sette A. Five HLA-DP Molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity. J. Immunol. 2010, 184:2492-2503.
50. Silva E.M., Fernandes M.I., Galvão L.C., Sawamura R., Donadi E.A. Human leukocyte antigen class II alleles in white Brazilian patients with celiac disease. J. Pediatr. Gastroenterol. Nutr. 2000, 31:391-394.
51. Song W., Ruder A.M., Hu L., Li Y., Ni R., Shao W., Kaslow R.A., Butler M., Tang J. Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs. PLoS ONE 2009, 4:e7157.
52. Tang J., Shao W., Dorak M.T., Li Y., Miike R., Lobashevsky E., Wiencke J.K., Wrensch M., Kaslow R.A., Cobbs C.S. Positive and negative associations of human leukocyte antigen variants with the onset and prognosis of adult glioblastoma multiforme. Cancer Epidemiol. Biomark. Prev. 2005, 14:2040-2044.
53. Tuokko J., Nejentsev S., Luukkainen R., Toivanen A., Ilonen J. HLA haplotype analysis in Finnish patients with rheumatoid arthritis. Arthritis Rheum. 2001, 44:315-322.
54. Wiemels J.A., Wilson D., Patil C., Patoka J., McCoy L., Rice T., Schwartzbaum J., Heimberger A., Sampson J.H., Chang S., Prados M., Wiencke J.K., Wrensch M. IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int. J. Cancer 2009, 125:680-687.
55. Wigertz A., Lönn S., Schwartzbaum J., Hall P., Auvinen A., Christensen H.C., Johansen C., Klaeboe L., Salminen T., Schoemaker M.J., Swerdlow A.J., Tynes T., Feychting M. Allergic conditions and brain tumor risk. Am. J. Epidemiol. 2007, 166:941-950.
56. Wrensch M., Wiencke J.K., Wiemels J., Miike R., Patoka J., Moghadassi M., McMillan A., Kelsey K.T., Aldape K., Lamborn K.R., Parsa A.T., Sison J.D., Prados M.D. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res. 2006, 66:4531-4541.